Recently, mechanisms that link BDNF regulation, tau phosphorylation, β-amyloid (Aβ) accumulation, and inflammation in AD were discussed [9] as follows: both pro-inflammatory cytokines and the toxic effects of Aβ deposition seem to be associated with alterations of BDNF release. Here, MAPT is linked to Alzheimer disease.